Aileron Therapeutics Inc (NASDAQ:ALRN) Climbs 54.53% In 2025; Is It Attractive Enough At $1.93?
In last trading session, Aileron Therapeutics Inc (NASDAQ:ALRN) saw 0.13 million shares changing hands with its beta currently measuring 2.25. Company’s recent per share price